Sunday, May 19, 2013 7:18am EDT
Weiss Michael S - Insider Transactions
SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
MDec 28 2012 | TGTX | Tg Therapeutics, Inc. | Weiss Michael S | Chairman, Interim CEO, Pres, 10% Owner | 486,743 | Grant at $0.00 | $0 | |
MSep 10 2012 | TGTX | Tg Therapeutics, Inc. | Weiss Michael S | See Remarks, 10% Owner | 150,000 | Purchase at $2.25 | $337,500 | |
Apr 30 2012 | TGTXD | Tg Therapeutics, Inc. | Weiss Michael S | See Remarks, 10% Owner | 3,524,560 | Converted deriv at $0.00 | $0 | |
May 16 2012 | TGTXD | Tg Therapeutics, Inc. | Weiss Michael S | See Remarks, 10% Owner | 1,500,000 | Grant at $0.00 | $0 | |
May 16 2012 | TGTXD | Tg Therapeutics, Inc. | Weiss Michael S | See Remarks, 10% Owner | 1,500 | Purchase at $6.25 | $9,375 | |
MApr 23 2010 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | 10% Owner | 627,649 | Sale at $5.40 | $3,389,995 | |
MApr 5 2010 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | 10% Owner | 460,200 | Sale at $3.81 | $1,753,038 | |
MApr 5 2010 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | 10% Owner | 350,000 | Option exercise at $1.30 | $455,000 | |
Nov 14 2008 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 1,800,000 | Grant at $0.00 | $0 | |
MAug 22 2008 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 150,000 | Purchase at $0.40 | $60,500 | |
MDec 15 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 37,344 | Option exercise at $1.30 | $48,547 | |
MDec 15 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 37,344 | Sale at $14.03 | $523,871 | |
MDec 12 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 59,224 | Option exercise at $1.30 | $76,991 | |
MDec 12 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 59,224 | Sale at $14.31 | $847,570 | |
MDec 11 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 18,500 | Sale at $14.47 | $267,640 | |
MDec 7 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 103,432 | Option exercise at $1.30 | $134,462 | |
MDec 7 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 84,932 | Sale at $14.59 | $1,239,133 | |
Jul 18 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 10,000 | Option exercise at $1.30 | $13,000 | |
MJul 18 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 10,000 | Sale at $11.61 | $116,098 | |
Jun 20 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Option exercise at $1.30 | $52,000 | |
MJun 20 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Sale at $12.61 | $504,547 | |
May 16 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Option exercise at $1.30 | $52,000 | |
MMay 16 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Sale at $15.32 | $612,933 | |
Apr 18 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chariman, CEO | 40,000 | Option exercise at $1.30 | $52,000 | |
MApr 18 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chariman, CEO | 40,000 | Sale at $17.09 | $683,472 | |
Mar 21 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 80,000 | Option exercise at $1.30 | $104,000 | |
MMar 21 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 80,000 | Sale at $18.28 | $1,462,376 | |
Feb 21 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Option exercise at $1.30 | $52,000 | |
MFeb 21 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Sale at $16.65 | $665,934 | |
Aug 5 2005 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 400 | Gift at $0.00 | $0 | |
Jun 8 2005 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 17,500 | Gift at $0.00 | $0 | |
Jun 4 2003 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 5,000 | Purchase at $1.75 | $8,750 | |
Mar 15 2005 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 550 | Gift at $0.00 | $0 | |
Mar 10 2005 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 4,800 | Gift at $0.00 | $0 | |
Nov 11 2004 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 3,600 | Gift at $0.00 | $0 | |
Oct 14 2004 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 500 | Gift at $0.00 | $0 | |
Jul 14 2004 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 500 | Gift at $0.00 | $0 | |
Jun 28 2004 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 11,000 | Gift at $0.00 | $0 | |
Jun 22 2004 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 3,750 | Gift at $0.00 | $0 | |
Jun 15 2004 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 5,000 | Purchase at $10.92 | $54,600 | |
Jun 9 2004 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 6,500 | Gift at $0.00 | $0 | |
Mar 17 2004 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 6,000 | Gift at $0.00 | $0 | |
Mar 17 2004 | GTNA | Genta Inc De/ | Weiss Michael S | Director | 6,000 | Gift at $0.00 | $0 | |
Dec 17 2003 | GNTA | Genta Inc De/ | Weiss Michael S | Director | 9,600 | Gift at $0.00 | $0 | |
MNov 21 2003 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 5,000 | Purchase at $4.25 | $21,261 |
D Derivative transaction exists
M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance